MedPath

Theradome, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Treatment of Androgenetic Alopecia in Males With Theradomeâ„¢ LH80 PRO

Phase 2
Conditions
Androgenetic Alopecia
Interventions
Device: LH80 PRO
Device: Sham Device
First Posted Date
2015-08-19
Last Posted Date
2016-12-02
Lead Sponsor
Theradome, Inc.
Target Recruit Count
80
Registration Number
NCT02528552
Locations
🇺🇸

Axis Clinical Tirals, Los Angeles, California, United States

🇺🇸

MedaPhase, Inc., Newnan, Georgia, United States

🇺🇸

NW Dermatology & Research Center, LLC, Portland, Oregon, United States

and more 1 locations
© Copyright 2025. All Rights Reserved by MedPath